Skip to main content
Equibles

Jaren Werbe

Analyst

TD Securities

Equibles does not estimate personal net worth.

About Jaren Werbe

Jaren Werbe is recorded as Analyst at TD Securities. Jaren Werbe has spoken on 1 earnings call across 1 company, most recently for Genmab A/S on February 17, 2026. The companies whose calls Jaren Werbe spoke on are classified in the Healthcare sector.

Jaren Werbe on recent calls

“So, quick question, just as a natural follow-up. The Origami 5 study, as you mentioned, uses Kichudan chemo as a combo, presumably in patients with more ebolicly aggressive disease and frontline.”
Analyst — TD Securities, Genmab A/S Q4 FY2025 Earnings Call ·

Affiliation history

  • TD Securities

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity